Julio Lopez Selected Research

Glucagon-Like Peptide 1 (GLP 1)

1/2020

Assessing the Continuation of Glucagon-Like Peptide-1 Receptor Agonists When Weight and HBA1C Are Not Reduced.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julio Lopez Research Topics

Disease

4	Diabetes Mellitus 01/2019 - 06/2003
3	Hypertension (High Blood Pressure) 01/2019 - 01/2007
1	Weight Loss (Weight Reduction) 01/2020
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2019
1	Hypercholesterolemia 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Pain (Aches) 09/2015
1	Hemorrhage 06/2014
1	Heart Failure 06/2003

Drug/Important Bio-Agent (IBA)

2	Antihypertensive Agents (Antihypertensives)IBA 04/2008 - 01/2007
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	Proton Pump InhibitorsIBA 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	Simvastatin (Zocor)FDA LinkGeneric 01/2019
1	Pregabalin (Lyrica)FDA Link 09/2015
1	Niacin (Nicotinic Acid)FDA LinkGeneric 02/2010
1	Glucose (Dextrose)FDA LinkGeneric 02/2010
1	Blood Glucose (Blood Sugar)IBA 02/2010
1	PotassiumIBA 04/2008
1	ThiazidesIBA 04/2008
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2003
1	Angiotensin Receptor AntagonistsIBA 06/2003

Therapy/Procedure

1	Glycemic Control 01/2019
1	Sutures (Suture) 06/2014
1	Gastrectomy 06/2014
1	Therapeutics 04/2008